Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation

Leighton R James, Damu Tang, Alistair Ingram, Hao Ly, Kerri Thai, Lu Cai, James W. Seholey

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

The hexosamine pathway may mediate some of the toxic effects of glucose. We hypothesized that flux through this pathway might regulate the activity of nuclear factor κB (NF-κB)-dependent genes in mesangial cells (MCs). In MCs, RT-PCR revealed that high glucose (30 mmol/l) and glucosamine (1 mmol/l) increased mRNA levels for vascular cell adhesion molecule 1 (VCAM-1) and increased the activity of an NF-κB enhancer by 1.5- and 2-fold, respectively. Overexpression of glutamine: fructose-6-phosphate amidotransferase (GFAT), the rate-limiting enzyme for flux through the hexosamine pathway, led to a 2.2-fold increase in NF-κB enhancer activity; the combination of GFAT overexpression and high glucose increased activity 2.8-fold, and these increases were prevented by 40 μmoll/l-diazoacetyl-L-serine (azaserine) or 6-diazo-5-oxonorleucine. High glucose, glucosamine, and GFAT overexpression increased binding of MC nuclear proteins to NF-κB consensus sequences. Immunoblotting revealed that the p65 subunit of NF-κB was O-glycosylated in MC cultured in physiologic glucose and that significant enhancement occurred with high glucose and glucosamine. Both glucose and glucosamine dose-dependently increased human VCAM-1 promoter activity. In addition, GFAT overexpression activated the VCAM-1 promoter (2.25-fold), with further augmentation by high glucose and abrogation by inhibitors of GFAT, NF-κB, and O-glycosylation. Inactivation of the two NF-κB sites in the VCAM-1 promoter abolished its response to high glucose, glucosamine, and GFAT overexpression. These results suggest that increased flux through the hexosamine pathway leads to NF-κB-dependent promoter activation in MCs.

Original languageEnglish (US)
Pages (from-to)1146-1156
Number of pages11
JournalDiabetes
Volume51
Issue number4
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Hexosamines
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
Mesangial Cells
Glucose
Glucosamine
Vascular Cell Adhesion Molecule-1
Poisons
Consensus Sequence
Nuclear Proteins
Glycosylation
Immunoblotting
Serine
Polymerase Chain Reaction
Messenger RNA

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation. / James, Leighton R; Tang, Damu; Ingram, Alistair; Ly, Hao; Thai, Kerri; Cai, Lu; Seholey, James W.

In: Diabetes, Vol. 51, No. 4, 01.01.2002, p. 1146-1156.

Research output: Contribution to journalArticle

James, Leighton R ; Tang, Damu ; Ingram, Alistair ; Ly, Hao ; Thai, Kerri ; Cai, Lu ; Seholey, James W. / Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation. In: Diabetes. 2002 ; Vol. 51, No. 4. pp. 1146-1156.
@article{83e16504d4d243baa3d004e0ecc6bdf5,
title = "Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation",
abstract = "The hexosamine pathway may mediate some of the toxic effects of glucose. We hypothesized that flux through this pathway might regulate the activity of nuclear factor κB (NF-κB)-dependent genes in mesangial cells (MCs). In MCs, RT-PCR revealed that high glucose (30 mmol/l) and glucosamine (1 mmol/l) increased mRNA levels for vascular cell adhesion molecule 1 (VCAM-1) and increased the activity of an NF-κB enhancer by 1.5- and 2-fold, respectively. Overexpression of glutamine: fructose-6-phosphate amidotransferase (GFAT), the rate-limiting enzyme for flux through the hexosamine pathway, led to a 2.2-fold increase in NF-κB enhancer activity; the combination of GFAT overexpression and high glucose increased activity 2.8-fold, and these increases were prevented by 40 μmoll/l-diazoacetyl-L-serine (azaserine) or 6-diazo-5-oxonorleucine. High glucose, glucosamine, and GFAT overexpression increased binding of MC nuclear proteins to NF-κB consensus sequences. Immunoblotting revealed that the p65 subunit of NF-κB was O-glycosylated in MC cultured in physiologic glucose and that significant enhancement occurred with high glucose and glucosamine. Both glucose and glucosamine dose-dependently increased human VCAM-1 promoter activity. In addition, GFAT overexpression activated the VCAM-1 promoter (2.25-fold), with further augmentation by high glucose and abrogation by inhibitors of GFAT, NF-κB, and O-glycosylation. Inactivation of the two NF-κB sites in the VCAM-1 promoter abolished its response to high glucose, glucosamine, and GFAT overexpression. These results suggest that increased flux through the hexosamine pathway leads to NF-κB-dependent promoter activation in MCs.",
author = "James, {Leighton R} and Damu Tang and Alistair Ingram and Hao Ly and Kerri Thai and Lu Cai and Seholey, {James W.}",
year = "2002",
month = "1",
day = "1",
doi = "10.2337/diabetes.51.4.1146",
language = "English (US)",
volume = "51",
pages = "1146--1156",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation

AU - James, Leighton R

AU - Tang, Damu

AU - Ingram, Alistair

AU - Ly, Hao

AU - Thai, Kerri

AU - Cai, Lu

AU - Seholey, James W.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The hexosamine pathway may mediate some of the toxic effects of glucose. We hypothesized that flux through this pathway might regulate the activity of nuclear factor κB (NF-κB)-dependent genes in mesangial cells (MCs). In MCs, RT-PCR revealed that high glucose (30 mmol/l) and glucosamine (1 mmol/l) increased mRNA levels for vascular cell adhesion molecule 1 (VCAM-1) and increased the activity of an NF-κB enhancer by 1.5- and 2-fold, respectively. Overexpression of glutamine: fructose-6-phosphate amidotransferase (GFAT), the rate-limiting enzyme for flux through the hexosamine pathway, led to a 2.2-fold increase in NF-κB enhancer activity; the combination of GFAT overexpression and high glucose increased activity 2.8-fold, and these increases were prevented by 40 μmoll/l-diazoacetyl-L-serine (azaserine) or 6-diazo-5-oxonorleucine. High glucose, glucosamine, and GFAT overexpression increased binding of MC nuclear proteins to NF-κB consensus sequences. Immunoblotting revealed that the p65 subunit of NF-κB was O-glycosylated in MC cultured in physiologic glucose and that significant enhancement occurred with high glucose and glucosamine. Both glucose and glucosamine dose-dependently increased human VCAM-1 promoter activity. In addition, GFAT overexpression activated the VCAM-1 promoter (2.25-fold), with further augmentation by high glucose and abrogation by inhibitors of GFAT, NF-κB, and O-glycosylation. Inactivation of the two NF-κB sites in the VCAM-1 promoter abolished its response to high glucose, glucosamine, and GFAT overexpression. These results suggest that increased flux through the hexosamine pathway leads to NF-κB-dependent promoter activation in MCs.

AB - The hexosamine pathway may mediate some of the toxic effects of glucose. We hypothesized that flux through this pathway might regulate the activity of nuclear factor κB (NF-κB)-dependent genes in mesangial cells (MCs). In MCs, RT-PCR revealed that high glucose (30 mmol/l) and glucosamine (1 mmol/l) increased mRNA levels for vascular cell adhesion molecule 1 (VCAM-1) and increased the activity of an NF-κB enhancer by 1.5- and 2-fold, respectively. Overexpression of glutamine: fructose-6-phosphate amidotransferase (GFAT), the rate-limiting enzyme for flux through the hexosamine pathway, led to a 2.2-fold increase in NF-κB enhancer activity; the combination of GFAT overexpression and high glucose increased activity 2.8-fold, and these increases were prevented by 40 μmoll/l-diazoacetyl-L-serine (azaserine) or 6-diazo-5-oxonorleucine. High glucose, glucosamine, and GFAT overexpression increased binding of MC nuclear proteins to NF-κB consensus sequences. Immunoblotting revealed that the p65 subunit of NF-κB was O-glycosylated in MC cultured in physiologic glucose and that significant enhancement occurred with high glucose and glucosamine. Both glucose and glucosamine dose-dependently increased human VCAM-1 promoter activity. In addition, GFAT overexpression activated the VCAM-1 promoter (2.25-fold), with further augmentation by high glucose and abrogation by inhibitors of GFAT, NF-κB, and O-glycosylation. Inactivation of the two NF-κB sites in the VCAM-1 promoter abolished its response to high glucose, glucosamine, and GFAT overexpression. These results suggest that increased flux through the hexosamine pathway leads to NF-κB-dependent promoter activation in MCs.

UR - http://www.scopus.com/inward/record.url?scp=0036231781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036231781&partnerID=8YFLogxK

U2 - 10.2337/diabetes.51.4.1146

DO - 10.2337/diabetes.51.4.1146

M3 - Article

VL - 51

SP - 1146

EP - 1156

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -